Showing results (421-430 of 559) with videos related to

Sort By:
Pageof 56
Journal of Medical Internet Research|July 7, 2020
A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and DevelopmentErica Schleimer, Jennifer Pearce, Andrew Barnecut, et al.
JMIR Formative Research|July 29, 2025
Feasibility and Acceptability of a Psychological Intervention for Internalized Health-Related Stigma Among Adults With Chronic Health Conditions: Preliminary InvestigationRebecca L Pearl, Danielle Saunders, Laurie C Groshon, et al.
The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.
Archives of Dermatology|August 17, 2011
High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of responseBrian A Raphael, Daniel B Shin, Karen R Suchin, et al.
The Journal of Investigative Dermatology|April 23, 2021
Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsAlvaro González-Cantero, Daniel Ortega-Quijano, Noelia Álvarez-Díaz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2025
Platelet Activation and a Platelet Biosignature Are Associated With Cardiovascular Risk in Patients With Controlled PsoriasisMichael S Garshick, Kamelia Drenkova, Filipp Kazatsker, et al.
JAMA Neurology|April 24, 2023
Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune SuppressionCaleb R S McEntire, Anita Fletcher, Michel Toledano, et al.
JAMA Neurology|September 1, 2018
Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus GroupBarney J Stern, Walter Royal, Jeffrey M Gelfand, et al.
Blood|August 1, 2015
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphomaAlain H Rook, Joel M Gelfand, Joel C Gelfand, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 8, 2020
Intrathecal B-cell activation in LGI1 antibody encephalitisKlaus Lehmann-Horn, Sarosh R Irani, Shengzhi Wang, et al.
Pageof 56